Evidence map›Paper›PMID 40491267›Full record

Observational studyJournal of comparative effectiveness research2025

Resource utilization and economic outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression: a retrospective observational analysis.

Joseph J Taylor, Andrew J Manett, Michael Feyder, Brandon S Bentzley

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of comparative effectiveness research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joseph J TaylorHarvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-9185-0427
Andrew J ManettBrain Stimulation Service, Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-4065-8013
Michael FeyderMagnus Medical Inc., Burlingame, CA 94010, USA.ORCID 0000-0001-5849-905X
Brandon S BentzleyMagnus Medical Inc., Burlingame, CA 94010, USA.

Funding

Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
Deriving TMS Targets for Mood Valence and Mood Stabilization in Bipolar DisorderK23MH129829 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI Joseph Jeffrey Taylor · 2022 to 2026
$978k
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trialR21AA030372 · NIAAA · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAI, PETER R, SUZUKI, JOJI · 2022 to 2023
$470k
NIAAA NIH HHS R21 AA030372NIMH NIH HHS K23 MH129829NIMH NIH HHS R01 MH113929
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Depressive Disorder, Treatment-ResistantPatient Acceptance of Health CareTranscranial Magnetic StimulationAgedFee-for-Service PlansFemaleHealth Care CostsHumansMaleMedicareMiddle AgedRetrospective StudiesUnited StatesEOC costsepisode of care costshealthcare utilizationmajor depressive disorderMDDrepetitive transcranial magnetic stimulationrTMSSAINT®SAINT® Neuromodulation SystemTRDtreatment-resistant depression

Identifiers

PMID40491267
PMCPMC12224075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.